Nursing Field Notes / Psych-Mental Health Pharmacology Β· Antidepressant Ladder β Rungs 2 & 3 of 3
SNRI vs. TCA
Two older or dual-acting antidepressant classes β one modern & broad, one older & risky
NG-187PSYCH PHARMADHD-friendly visual edition
SNRIs block reuptake of two neurotransmitters β serotonin AND norepinephrine β and double as neuropathic pain drugs. TCAs are an older class that also boosts serotonin & norepinephrine, but drags a heavy anticholinergic side-effect profile and a genuinely dangerous overdose behind it. Same neurotransmitter targets, very different safety margins β that's the whole point of this comparison.
π― SNRI = dual + painSerotonin AND norepinephrine reuptake blocked β also treats neuropathic/fibromyalgia pain.
π TCA = narrow marginCardiotoxic in overdose β QT prolongation, arrhythmia. A small extra dose can kill.
π₯΄ TCA = anticholinergic"Can't see, can't pee, can't spit, can't poop" β the classic tetrad.
π¨ Serotonin syndromeAgitation, hyperthermia, clonus/hyperreflexia, diaphoresis, tremor β same 5 signs, same risk, both classes.
π£
SIDE A Β· SNRI
STEP 1 Β· DUAL & MODERN
Rung 2 of the ladder β same serotonin trick as an SSRI, plus norepinephrine, plus a second job treating chronic pain.
π¬ Blocks TWO reuptake pumps at once
MOA Like an SSRI, an SNRI blocks the serotonin reuptake pump β but it also blocks the norepinephrine reuptake pump, so both neurotransmitters build up in the synapse. That second target is what gives SNRIs their extra job: treating neuropathic pain, not just mood.
π§ βSNRI = double duty.β One drug, two pumps blocked, two jobs done: mood and pain.
π§ "If a fibromyalgia patient on duloxetine says they're not depressed, they need education" β it's still the right drug. It's treating their pain, not (only) their mood.
β Key point β pain AND sleep
Duloxetine helps with chronic pain and improves sleep quality in fibromyalgia patients β a two-for-one benefit worth pointing out in patient teaching.
π§ SNRIs are often reached for second, after an SSRI trial, or first when chronic pain is part of the picture.
π΅
SIDE B Β· TCA
STEP 2 Β· OLDER & RISKIER
Rung 3 of the ladder β an older class that hits more receptors than it needs to, and that's exactly the problem.
π₯΄ The anticholinergic tetrad β "dry body"
TCAs don't just block serotonin/norepinephrine reuptake β they also block acetylcholine receptors, causing a predictable dry-everything picture.
π§ "Amy trips on things" β Amitriptyline causes orthostatic hypotension: teach slow position changes to avoid a dizzy fall. Imipramine β "Inhibit my PEEing" = urinary retention is its stand-out anticholinergic effect.
π Know the names
Amitriptyline β orthostatic hypotension
Imipramine β urinary retention
Indications: depression, anxiety, and neuropathic pain (diabetics & fibromyalgia) β TCAs treat pain too, like SNRIs, just with a rougher side-effect trade-off.
π§ Two drugs, two classic teaching points: Amitriptyline = slow rise. Imipramine = slow stream.
π Cardiotoxicity β the reason TCAs fell out of favor
Narrow safety margin β in overdose, TCAs cause QT prolongation and life-threatening cardiac arrhythmias. Unlike SSRIs/SNRIs, a TCA overdose is a genuine cardiac emergency.
π§ "TCAs can stop a heart before they stop a headache." A small dose miscalculation or an overdose attempt with a narrow-margin drug like this is a true cardiac emergency β assess for arrhythmia, monitor ECG.
βοΈ
TELL THEM APART
STEP 3 Β· SIDE BY SIDE
Same neurotransmitter targets, very different risk profile β this is the table the "vs." title is asking for.
Ladder position: older, generally reserved when newer agents fail
π§ "Same targets, different manners." Both hit serotonin + norepinephrine β the TCA just also grabs receptors it didn't need to, and that's where all its side effects and its overdose danger come from.
π¨ Both interact with MAOIs the same dangerous way
Never combine an SNRI or a TCA with an MAOI β risk of serotonin syndrome. A 2-week washout period is required when switching to or from an MAOI.
π§ "MAOI = Anti... depressant STOP." Whichever antidepressant a patient is switching away from or onto an MAOI, count two weeks first. See NG-154 for the full MAOI washout rule.
πͺ Where these two sit on the antidepressant ladder
πͺ This page = Rungs 2 & 3 Β· see NG-205 (SSRI) and NG-154 (MAOI) for the rest of the ladder